glp-1 euglycemic dka Complementary Yet Distinct Roles of Receptor Agonists and SGLT2 Inhibitors in Cardiovascular Risk Reduction GLP-1 receptor agonists are increasingly

The pharmacokinetics and pharmacodynamics of these hydrogel-based long-acting GLP-1 RA treatments are promising for development of novel therapies reducing treatment burden for more effective management of T2D

Also good if youre dealing with dullness, rough texture, fine lines, or redness

No treatment produces overnight results

Christopher Damman, Associate Professor of Gastroenterology, School of Medicine, University of Washington This article is republished from The Conversation under a Creative Commons license

2013 (6) CD008955

GLP-1 helps regulate blood sugar by stimulating insulin release, suppressing glucagon (which raises blood sugar), and slowing gastric emptying